Sean Wuxiong Cao, Chief Business Development Officer at NovaBridge Biosciences (NBP), sold 107,978 shares at $0.74 ($80K) on 2026-09-09, disclosed to the SEC on 2026-09-11.
Open-market sale of $80k NBP by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.